January 6, 2014 | The FDA has kicked off the new year by cleaning up its muddle of web pages for guidance documents, the crucial advisory papers that clarify the agency's position on niche types of drugs, medical devices and other regulated products. These documents are now available in a single, searchable database, which includes draft guidances awaiting a final agency decision. RAPS